Brain cell implant trial aims to tame Parkinson's
NCT ID NCT06753331
First seen Jan 07, 2026 · Last updated Jun 23, 2026 · Updated 29 times
Summary
This study tests a new treatment called DSP-1083, which involves implanting cells into the brain to help control Parkinson's disease symptoms. About 25 people with Parkinson's will either get the real implant or a sham surgery to see if it's safe and works. The goal is to improve movement and reduce the need for daily medication.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON´S DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
New York Presbyterian Hospital-Columbia University Medical Center
RECRUITINGNew York, New York, 10032, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Kentucky Medical Center
RECRUITINGLexington, Kentucky, 40536, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
DSP-1083 (a cell therapy implanted into the brain)
What this could lead to
If successful, this could point toward a new way to control Parkinson's symptoms by replacing lost brain cells, potentially reducing the need for medication.
What could go wrong
This is an early phase 1/2 trial with only 25 people, so results are preliminary. Risks include surgical complications, brain swelling, or the cells not working as hoped.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.